Literature DB >> 19781116

Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia.

Z Gao1, H F Gidding, J G Wood, C R MacIntyre.   

Abstract

We examined the impact of one-dose vs. two-dose vaccination strategies on the epidemiology of varicella zoster virus (VZV) in Australia, using a mathematical model. Strategies were assessed in terms of varicella (natural and breakthrough) and zoster incidence, morbidity, average age of infection and vaccine effectiveness (VE). Our modelling results suggest that compared to a one-dose vaccination strategy (Australia's current vaccination schedule), a two-dose strategy is expected to not only produce less natural varicella cases (5% vs. 13% of pre-vaccination state, respectively) but also considerably fewer breakthrough varicella cases (only 11.4% of one-dose strategy). Therefore a two-dose infant vaccination programme would be a better long-term strategy for Australia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19781116     DOI: 10.1017/S0950268809990860

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  13 in total

1.  Varicella vaccination programs do not seem to shift the age of disease to older age groups.

Authors:  Manuel García Cenoz
Journal:  Transl Pediatr       Date:  2014-10

2.  Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study.

Authors:  Anita E Heywood; Han Wang; Kristine K Macartney; Peter McIntyre
Journal:  Bull World Health Organ       Date:  2014-06-13       Impact factor: 9.408

3.  The Epidemiology of Herpes Zoster After Varicella Immunization Under Different Biological Hypotheses: Perspectives From Mathematical Modeling.

Authors:  Giorgio Guzzetta; Piero Poletti; Stefano Merler; Piero Manfredi
Journal:  Am J Epidemiol       Date:  2016-03-18       Impact factor: 4.897

4.  Incidence of varicella and herpes zoster after inclusion of varicella vaccine in national immunization schedule in Turkey: time trend study.

Authors:  Ahmet Soysal; Erdem Gönüllü; İsmail Yıldız; Metin Karaböcüoğlu
Journal:  Hum Vaccin Immunother       Date:  2020-07-23       Impact factor: 3.452

5.  Varicella Vaccination Two-Dose Recommendations: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors:  Ben Tan; Shainoor Ismail
Journal:  Can Commun Dis Rep       Date:  2010-09-20

6.  Epidemiological characteristics of breakthrough varicella infection during varicella outbreaks in Shanghai, 2008-2014.

Authors:  Y F Zhu; Y F Li; Y DU; M Zeng
Journal:  Epidemiol Infect       Date:  2017-04-27       Impact factor: 4.434

7.  Increasing trends of herpes zoster in Australia.

Authors:  Raina MacIntyre; Alicia Stein; Christopher Harrison; Helena Britt; Abela Mahimbo; Anthony Cunningham
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240

8.  Sero-Prevalence of Antibodies against Varicella Zoster Virus in Children under Seven-Years Old in 2012 in Tehran, Iran.

Authors:  Yasaman Vojgani; Saeed Zarei; Samira Rajaei; Leili Chamani-Tabriz; Fatemeh Ghaemimanesh; Nematallah Mohammadinia; Mahmood Jeddi-Tehrani
Journal:  Iran J Public Health       Date:  2014-11       Impact factor: 1.429

9.  Control of varicella in the post-vaccination era in Australia: a model-based assessment of catch-up and infant vaccination strategies for the future.

Authors:  Z Gao; J G Wood; H F Gidding; A T Newall; R I Menzies; H Wang; P B McIntyre; C R MacIntyre
Journal:  Epidemiol Infect       Date:  2014-09-15       Impact factor: 4.434

10.  Herpes zoster surveillance using electronic databases in the Valencian Community (Spain).

Authors:  Nuria Morant-Talamante; Javier Diez-Domingo; Sergio Martínez-Úbeda; Joan Puig-Barberá; Sara Alemán-Sánchez; Lina Pérez-Breva
Journal:  BMC Infect Dis       Date:  2013-10-05       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.